Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “reboxetine”

9 pharma patents match "reboxetine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "reboxetine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “reboxetine” · 30,257 patents in full index Clear search

  1. US 12246023

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  2. US 12115165

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  3. US 11957686

    Compositions for delivery of reboxetine

    AXSOME THERAPEUTICS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  4. US 11883408

    Reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  5. US 11364245

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  6. US 11351175

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  7. US 11185547

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  8. US 11135226

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  9. US 11020402

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted